Distinct Characteristics of Circulating Vascular Endothelial Growth Factor-A and C Levels in Human Subjects

Evidence for a Relationship between VEGF and BMI Independent of Insulin Sensitivity by Glucose Clamp Procedure in a Homogenous Group Healthy Young Men

(2010) Michaela Loebig et al.   PLoS One

Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study

(2009) A. Sandhofer et al.   ATHEROSCLEROSIS

Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance

(2009) Hiromichi Wada et al.   ATHEROSCLEROSIS

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

(2009) Marja Lohela et al.   CURRENT OPINION IN CELL BIOLOGY

Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: Correlation with clinical parameters and outcome

(2009) Roger Mouawad et al.   EUROPEAN JOURNAL OF CANCER

Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth

(2009) Romulo J C Albuquerque et al.   NATURE MEDICINE

Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C–dependent buffering mechanism

(2009) Agnes Machnik et al.   NATURE MEDICINE